This aspect enhances the vaccine’s immune response, favoring a humoral response, which is important in the context of prophylaxis against COVID-19, relying on the production of neutralizing antibodies against the Spike and Nucleocapsid proteins of SARS-CoV-2. Here, CHMP5 is linked to COVID-19.